ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-5.65%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$234M
AUM Growth
+$234M
Cap. Flow
+$113M
Cap. Flow %
48.11%
Top 10 Hldgs %
95.43%
Holding
14
New
2
Increased
2
Reduced
–
Closed
–

Top Buys

1
BBIO icon
BridgeBio Pharma
BBIO
$103M
2
BCEL
Atreca, Inc. Class A Common Stock
BCEL
$7.3M
3
ZSAN
Zosano Pharma Corporation
ZSAN
$1.4M
4
SYRE icon
Spyre Therapeutics
SYRE
$481K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$103M 44.18%
+3,835,722
New +$103M
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$34.9M 14.92%
1,123,630
– –
MRKR icon
3
Marker Therapeutics
MRKR
$12M
$15.8M 6.77%
2,000,000
– –
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
$15.7M 6.7%
1,386,338
– –
TECX
5
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$13.2M 5.64%
811,998
– –
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$12M 5.13%
274,513
– –
SYRE icon
7
Spyre Therapeutics
SYRE
$996M
$8.84M 3.78%
1,291,151
+70,240
+6% +$481K
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$7.3M 3.12%
+387,653
New +$7.3M
ZSAN
9
DELISTED
Zosano Pharma Corporation
ZSAN
$6.63M 2.83%
2,028,571
+428,571
+27% +$1.4M
VIRX
10
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.55M 2.37%
7,600,000
– –
NBRV
11
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.4M 1.88%
1,809,259
– –
RCUS icon
12
Arcus Biosciences
RCUS
$1.13B
$2.65M 1.13%
333,333
– –
VRNA
13
Verona Pharma
VRNA
$9.16B
$2.26M 0.97%
443,596
– –
ACRS icon
14
Aclaris Therapeutics
ACRS
$209M
$1.39M 0.59%
634,455
– –